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Abstract
Objective: Methicillin-resistant Staphylococcus epidermidis (MRSE) remains one of the most prevalent drug-resistant bacteria caus-
ing health care infections. Limited data are available about how the frequency of MRSE changed in Iran over the past years. The
current study aimed at determining the frequency of MRSE in different cities of Iran.
Methods: Databases including Web of Sciences, Scopus, Embase, Medline, and Iranian databases were searched to find studies ad-
dressing the frequency of MRSE in Iran published from Mar 2006 to Jan 2016. The data were analyzed using comprehensive meta-
analysis version 2.2 (Biostat). Of the 139 records identified in the databases, 15 studies met the inclusion criteria.
Results: The analyses showed that the frequency of MRSE infections was 73.9% [95% confidence interval (95% CI) 61.4 - 83.4] among
culture-positive cases of S. epidermidis in different parts of Iran. The frequency of MRSE was higher in the studies conducted from
2011 to 2015, based on further stratified analyses.
Conclusions: The regular surveillance on antimicrobial susceptibility pattern and formulation of definite antibiotic policy may
control high rate of MRSE associated infections in Iran. Moreover, rapid and reliable diagnosis of MRSE isolates and regular screening
of the personnel and surfaces of hospitals in terms of MRSE are indispensable.
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1. Context
Health care complication due to coagulase negative
staphylococci (CoNS) are increased worldwide (1, 2). CoNS
were known as major human skin resident organisms and
nowadays they are considered as one of the most impor-
tant agents of frequent nosocomial infections (3-5). Based
on recent studies, in patients that should be hospitalized
and use indwelling medical devices, Staphylococcus epider-
midis (S. epidermidis) is characterized as one of the main
opportunistic pathogens and the number of life threaten-
ing cases of biomaterial related infections are intensified
in many communities (6-9). The number of methicillin-
resistant S. epidermidis (MRSE) infections is dramatically in-
creased and is a serious problem in terms of nosocomial
infections worldwide (10). In the past 10 years, an alarm-
ing increase in the prevalence of MRSE is observed (11, 12).
Previously, S. epidermidis was described as a commensal hu-
man skin and mucosa micro flora (13, 14). Its appearance
in laboratory samples was interpreted as a confusing acci-
dental contamination, but now with the development of
implanted devices in modern medicine, researcher grad-
ually observed a relationship between chronic infections
and the use of these prosthetic tools (15, 16). The vast ma-
jority of studies insisted on the role of S. epidermidis in
catheter-associated infections that relies on bacterial ca-
pacity to colonize on such devices and protect itself from
host immunity or antibiotic therapy (17-20). Emergence
of S. epidermidis strains resistant to strong antibiotics in-
creased recently and made momentous severity to manage
the disease and health care control (21, 22). Moreover, MRSE
is one of the main post surgery infectious elements (23).
The close scrutiny of the rising number of MRSE isolates di-
vulges concern for diagnosis, control, and treatment (24).
To the best authors knowledge, there was no comprehen-
sive analysis of MRSE infection prevalence in Iran. Further-
more, few studies reported the prevalence of MRSE infec-
tions. The current study mainly aimed at assessing the
prevalence of MRSE infection in Iran.
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2. Methods
2.1. Search Strategies
From 2006 to June 2016, all studies discussing MRSE
infections in Iran were collected from databases of Web
of Science, PubMed, Scopus, Embase, Cochrane Library,
Iranmedex, Google Scholar, and Scientific Information
Database (SID). The search was restricted to original re-
search articles published in English or Persian and present-
ing the frequency or incidence of MRSE infections in Iran.
The following keywords containing Medical Subject Head-
ings (MeSh) or keywords in titles or abstracts were used
with Boolean operators (“and” or “or”): “Staphylococcus
epidermidis”, “S. epidermidis”, “coagulase negative staphy-
lococcus”, “CoNS”, “MRSE”, “methicillin-resistant Staphylo-
coccus epidermidis”, and “Iran”. Meanwhile, bibliographies
from retrieved papers were revised for any additional
studies. In addition to English papers, all relevant articles
in Iranian databases such as Magiran (www.magiran.com),
Iranmedex (www.iranmedex.com), Scientific Informa-
tion Database (www.sid.ir), Iranian National Library
(www.nlai.ir), and Irandoc (www.irandoc.ac.ir) were
searched with similar strategy and the related Persian
keywords. Furthermore, no contact was made with the
authors regarding the previous experiences (25-28).
2.2. Inclusion and Exclusion Criteria
All original articles presenting cross sectional studies
on the frequency of MRSE in Iran were considered. The se-
lection of articles for review was completed based on three
stages: titles, abstracts, and full texts. The inclusion crite-
ria were application of standard methods for drug suscep-
tibility testing (DST) of S. epidermidis against beta-lactam
antibiotics (penicillin, methicillin, oxacillin and cefoxitin)
and presenting data on the number of S. epidermidis and
MRSE isolates. Standard DST methods include the oxacillin
screening plate, broth microdilution (BMD), Epsilon test
(E test), disk diffusion method (DDM) for cefoxitin, and
polymerase chain reaction (PCR) technique for mecA detec-
tion. Studies were excluded from analysis for any of the fol-
lowing reasons: considering only specific subpopulation,
irrelevancy of the title, studies on non-human samples,
not reporting S. epidermidis numbers, application of non-
standard methods for MRSE detection, and not reporting
MRSE numbers. Review articles, meta-analyses or system-
atic reviews, duplicate publications of the same study and
articles available only in abstract form were also excluded
from the current study.
2.3. Data Extraction and Definitions
For all studies, the following data were extracted: the
first author’s name, year of publication, year of study, study
setting, number of cases investigated, method of studies,
source of samples, sample size, frequency of S. epidermidis
and MRSE, and if existed, other information. All the in-
cluded studies were extracted independently by two inves-
tigators and results were reviewed by a third investigator
and finally inconsistencies were discussed to achieve con-
sensus. PRISMA guidelines were used for the current study
(29).
2.4. Quality Assessment
Included studies were appraised for quality, using a
quality assessment checklist designed by the Joanna Briggs
Institute (29).
2.5. Meta-Analysis
Comprehensive meta-analysis version 2.0 (Biostat) was
used for analysis. The point estimate of effect size, the fre-
quency of MRSE, and its 95% confidence interval (95% CI)
were approximated for each survey. Random-effects mod-
els were utilized. Cochran Q-statistic was used to consider
the possibility of heterogeneity between the studies. To as-
sess possible publication bias, Egger weighted regression
methods were applied. P < 0.05 was considered indicative
of statistically significant publication bias.
3. Results
3.1. Characteristics of the Reviewed Articles
Primarily, 139 studies were selected and in the next
screening, 26 of them were included based on title and ab-
stract screening (Figure 1). In the third phase, 20 of the 26
article were selected upon a full text search and finally 15
eligible articles were selected (Figure 1). Table 1 shows the
details of the reviewed studies (30-44). Geographical lo-
cation of studies mostly covered center and west of Iran.
Moreover, MRSE isolates were isolated from different clini-
cal samples, especially blood.
3.2. The Frequency of MRSE Infections
The rate of MRSE infections among culture-positive
cases of S. epidermidis was 73.9% (95% CI: 61.4 - 83.4) (Ta-
ble 2). The heterogeneity evaluation showed heterogeneity
among articles (I2 = 95.327, P < 0.001). Forest plot of meta-
analysis on the rate of MRSE infections are indicated in Ta-
ble 2 and Figure 2. According to Table 2 and Figure 3, there
was no publication bias in the current study (P > 0.05 for
Egger weighted regression analysis). Table 3 demonstrated
the stratified analyses based on the geographical locations
of the reviewed articles. Distribution of MRSE infections in
different parts of Iran is revealed in Figure 4.
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139 PubMed, Web of Science,Embase, Cochrane 
library, Scopus and Iranian databases 
104 Articles Excluded
Title Not Relevant; N = 56 
Studies on Non Human Samples; N = 43 
Review Articles; N = 5
35 Abstracts Reviewed
6 Articles Excluded
Studies on Non Human Samples; N = 6
29 Full-Text Articles Reviewed
14 Artiles Excluded 
Not reported MRSE  Data; N = 7
Non Standard Method for MR SE Detection; N = 4
Duplicated Data; N = 3
15 Studies Included in the Meta- Analyis 
Figure 1. Flowdiagram of study
4. Discussion
The incidence of MRSE is gradually rising since its
emergence was reported. Although there were occasional
reports of MRSE infections in the past, it is one of the re-
cently established nosocomial pathogens (45). The cur-
rent systematic review reports the frequency of MRSE in-
fections in Iran. The current study analyses showed that
the frequency of MRSE infections was 73.9% (95% CI: 61.4
- 83.4) among culture-positive samples of S. epidermidis in
different parts of Iran (Table 2). According to the results
of the current study, the MRSE had higher incidence rate
in Tabriz, Arak, Sanandaj, and Isfahan than Tehran. Despite
the large population in Tehran, capital of Iran, better infec-
tion control policies in Tehran may reduce the MRSE inci-
dence than other parts of Iran. Although no article was re-
lated to the studies in the east of Iran, data showed that the
rate of MRSE infections were higher in the western parts
of Iran than the other parts. Also, the obtained results
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Table 1. Characteristics of Studies Included in Meta-Analysis
Study Time of Study Publication Data City No. of S.
epidermidis
No. of MRSE
Isolates
Diagnostic
Methods for
MRSE (CLSI)
Source of
Samples
Ebrahimzadeh
Namvar (36)
2014 2014 Isfahan 115 96 PCR/DDM Blood, catheters
Pishva (37) 2009 2013 Isfahan 146 103 E test -
Eftekhar (31) 2007 2011 Tehran 55 50 DDM Blood, wound
Pourmand (38) 2008 2011 Tehran 99 56 DDM Nasal swab
Taheri (43) 2013 2014 Arak 54 40 E test/PCR Surfaces and Staff
Soroush (42) 2012 - 2013 2016 Tehran 256 80 PCR Different
Havaei (34) 2014 2015 Isfahan 70 61 DDM/PCR Blood, catheters
Najar-Peerayeh
(35)
2010 - 2011 2014 Tehran 64 59 PCR Different
Shoja (41) 2006 2006 Tabriz 100 89 DDM/PCR Blood
Fateh Rahimi (32) 2014 2014 Tehran 193 72 E test/PCR Body fluid and
wound
Raei (39) 2007 2010 Tehran 55 42 PCR Blood
Ramazanzadeh
(40)
2011-2012 2015 Sanandaj 170 151 DDM Clinical sample,
staff
Ghotaslou (33) 2012 - 2013 2014 Tabriz 57 46 PCR Blood, tracheal
tube
Sotoudeh Anvari
(30)
2007 - 2012 2015 Tehran 20 7 DDM Pericardial
effusions
Talebi (44) 2010 - 2012 2015 Tehran 90 58 PCR/BMD -
Abbreviations: BMD, broth microdilution; DDM, disk diffusion method; E test, Epsilon test; PCR, polymerase chain reaction.
Table 2. Meta-Analysis of the Prevalence of MRSE Infections in Iran
Subgroup No. of Study Prevalence of MRSE
(95%CI)
n/N Heterogeneity
Test, I2 (%)
Heterogeneity
Test, P Value
Egger Test, t Egger Test, P Value
Overall effects 15 73.9 (61.4 - 83.4) 1010/1544 95.327 < 0.001 3.887 0.001
Researches from
2006 to 2010
6 73.3 (58.0 - 84.5) 347/475 88.596 < 0.001 0.619 0.569
Researches from
2011 from 2015
9 74.3 (55.9 - 86.9) 663/1069 96.627 < 0.001 4.997 0.001
Table 3. Meta-Analysis of the Prevalence of MRSE Infections in Different Parts of Iran
City No. of Study Prevalence of MRSE
(95%CI)
n/N Heterogeneity
Test, I2 (%)
Heterogeneity
Test, P Value
Egger Test, t Egger Test, P Value
Overall effects 15 73.9 (61.4 - 83.4) 1010/1544 95.327 < 0.001 3.887 0.001
Tehran 8 63.3 (46.6 - 77.4) 424/832 94.221 < 0.001 3.224 0.017
Isfahan 3 80.6 (68.5 - 88.8) 260/331 79.842 < 0.001 2.727 0.223
Tabriz, Arak,
Sanandaj
4 84.3 (76.4 - 89.9) 326/381 66.090 < 0.001 0.944 0.444
showed that MRSE incidence rates increased from 2011 to
2015 [74.3% (95% CI: 55.9 - 86.9)] in comparison with other
studies, from 2006 to 2010. This event had several reasons
such as increasing rate of MRSE during the recent years, the
increase of knowledge about MRSE recognition, and use of
advanced devices and methods such as E test and PCR for
MRSE identification, etc.
Hospital-acquired infections, according to centers for
disease control (CDC), are the infection that is acquired
in a hospital or other health care facilities after 2 days of
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Figure 2. Forest plot of meta-analysis on the prevalence of MRSE infection
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Figure 3. Funnel plot of meta-analysis on the prevalance of MRSE infections
admission. High population societies, such as Iran, with
less attention to hygienic practices and standards in some
parts of the country can be regarded as the main factor
for hospital-acquired infections (46). There is little infor-
mation about the different SCCmec types of MRSE in Iran.
In agreement with prior information, the rate of SCCmec
in types I and II was low, while type IV was comparatively
prevalent (47, 48). According to the results of an inves-
tigation, SCCmec type IV was the most prevalent type fol-
lowed by type V and III in MR-CoNS strains, respectively
(49). Also, another study indicated that 36% of MRSE iso-
lates had a type IV of SCCmec (50). Based on the recent infor-
mation, origin of SCCmec is more various in MR-CoNS via
novel types of ccr genes (51). Other factors that can raise
MRSE incidence are the intensity of disease, transition of
pathogenic bacteria among the hospital wards, the dis-
organized implementation of prophylactic hygiene mea-
sures, inadequate staff training, and lack of hospital in-
fection control programs. Thus, insufficient MRSE man-
agement leads to the continued spread of MRSE in hos-
pitals of Iran. Moreover, the association of multidrug re-
sistance with MRSE adds to the problem (52). B-lactam
antibiotics such as penicillin and cephalexin were not ef-
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Figure 4. Distribution of MRSE infection in Iran based on the rate of incidence
fective against MRSE (53, 54). The maximum impressive
antibacterial drugs against S. epidermidis were cefoxitin,
ciprofloxacin, and gentamicin. Therapy for patients with
staphylococcal infections is made hard by bacterial resis-
tances to beta-lactams and other antibacterial agents such
as aminoglycosides and glycopeptides. Lately offered or
empirical drugs such as dalfopristin and quinupristin be-
longing to streptogramin class, and linezolid may be ben-
eficial in the treatment of patients with multi-drug resis-
tant staphylococci infections (30, 55). MRSE can be noso-
comial or community-acquired. MRSE can be defined as
community-acquired if the positive culture is obtained in
less than two days of admission or outside hospital set-
tings (56). Due to the lack of enough information, it is
not exactly claimed whether the MRSE were from com-
munity or hospital. Another notable point is some lim-
itations to perform this investigation, which should be
discussed. First of all, only published studies were ac-
cepted for including in the current meta-analysis. Then,
biases between publications and systematic reviews were
inevitable. Second, heterogeneity was observed among the
studies. Third, since there was no study on MRSE infections
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in many regions of Iran, it cannot fully represent the fre-
quency of MRSE in Iran. Fourth, since it was a prevalence
survey, it is not possible to determine the risk factors for
MRSE colonization or infection.
In conclusion, high rate of MRSE isolates is a public
health problem in Iran that needs further attention by mi-
crobiologists, health authorities, and physicians. The reg-
ular surveillance on antimicrobial susceptibility patterns
and formulation of definite antibiotic policy may control
high rates of MRSE associated infections in Iran. Moreover,
rapid and reliable diagnosis of MRSE isolates and regular
screening of the hospitals surfaces and personnel in terms
of MRSE are indispensable.
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